UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 64

Sortiert nach

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

European urology, 2019-12, Vol.76 (6), p.831-842

2019

Volltextzugriff (PDF)

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

JNCI : Journal of the National Cancer Institute, 2013-06, Vol.105 (11), p.812-822

2013

Volltextzugriff (PDF)

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

Cancer epidemiology, biomarkers & prevention, 2012-01, Vol.21 (1), p.134-147

2012

Volltextzugriff (PDF)

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

The lancet oncology, 2021-11, Vol.22 (11), p.1618-1631

2021

Volltextzugriff (PDF)

technical knockout, a Drosophila Model of Mitochondrial Deafness

Genetics (Austin), 2001-09, Vol.159 (1), p.241-254

2001

Volltextzugriff (PDF)

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

European urology, 2014-09, Vol.66 (3), p.489-499

2014

Volltextzugriff (PDF)

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

Cancer research (Chicago, Ill.), 2010-12, Vol.70 (23), p.9742-9754

2010

Volltextzugriff (PDF)

A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer

BMC cancer, 2016-07, Vol.16 (1), p.529-529, Article 529

2016

Volltextzugriff (PDF)

Psychosocial impact of undergoing prostate cancer screening for men with BRCA 1 or BRCA 2 mutations

BJU international, 2019-02, Vol.123 (2), p.284-292

2019

Volltextzugriff (PDF)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Breast cancer research : BCR, 2014-12, Vol.16 (6), p.3416-3416, Article 3416

2014

Volltextzugriff (PDF)

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Human molecular genetics, 2011-08, Vol.20 (16), p.3304-3321

2011

Volltextzugriff (PDF)

Building the Genetic Counsellor Profession in the United Kingdom: Two Decades of Growth and Development

Journal of genetic counseling, 2013-12, Vol.22 (6), p.902-906

2013

Volltextzugriff (PDF)

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Breast cancer research : BCR, 2011-01, Vol.13 (6), p.R110-R110, Article R110

2011

Volltextzugriff (PDF)

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Human molecular genetics, 2010-07, Vol.19 (14), p.2886-2897

2010

Volltextzugriff (PDF)

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

Human mutation, 2012-04, Vol.33 (4), p.690-702

2012

Volltextzugriff (PDF)

Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

JNCI : Journal of the National Cancer Institute, 2011-01, Vol.103 (2), p.105-116

2011

Volltextzugriff (PDF)

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

British journal of cancer, 2012-06, Vol.106 (12), p.2016-2024

2012

Volltextzugriff (PDF)

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

Human molecular genetics, 2011-12, Vol.20 (23), p.4732-4747

2011

Volltextzugriff (PDF)

Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High-Risk Mutations

Genetic epidemiology, 2012-04, Vol.36 (3), p.274-291

2012

Volltextzugriff (PDF)

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

PloS one, 2012-06, Vol.7 (6), p.e35706-e35706

2012

Volltextzugriff (PDF)

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

Human genetics, 2011-11, Vol.130 (5), p.685-699

2011

Volltextzugriff (PDF)

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

British journal of cancer, 2011-04, Vol.104 (8), p.1356-1361

2011

Volltextzugriff (PDF)

Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

Breast cancer research and treatment, 2010-07, Vol.122 (1), p.281-285

2010

Volltextzugriff (PDF)

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

Breast cancer research and treatment, 2009-09, Vol.117 (2), p.371-379

2009

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(64)

Sprache

Englisch
(64)
Japanisch
(14)

Erscheinungsjahr

n.n

Thema

Science & Technology
(55)
Life Sciences & Biomedicine
(53)
Humans
(41)
Female
(30)
Exercise
(21)
Mutation
(19)
Adult
(18)
Middle Aged
(18)
Children
(17)
Genetic Predisposition To Disease
(17)
Health Aspects
(17)
Physical Fitness
(17)
Analysis
(16)
Breast Neoplasms - Genetics
(16)
Heterozygote
(16)
Medicin Och Hälsovetenskap
(16)
Public, Environmental & Occupational Health
(16)
Literacy
(15)
Male
(15)
Physical Activity
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

technical knockout, a Drosophila Model of Mitochondrial Deafness

Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

A cohort analysis of men with a family history of BRCA1/2 and Lynch mutations for prostate cancer

Psychosocial impact of undergoing prostate cancer screening for men with BRCA 1 or BRCA 2 mutations

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers

Building the Genetic Counsellor Profession in the United Kingdom: Two Decades of Growth and Development

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

Genetic Variation at 9p22.2 and Ovarian Cancer Risk for BRCA1 and BRCA2 Mutation Carriers

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study

Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers

Evaluation of Association Methods for Analysing Modifiers of Disease Risk in Carriers of High-Risk Mutations

Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2

Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers

Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2

Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers

No evidence that GATA3 rs570613 SNP modifies breast cancer risk

Predicting breast cancer risk: implications of a “weak” family history

Suchergebnisse filtern